CG Oncology, Inc. has been added to Nasdaq Composite Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.31 USD | +5.69% | -19.56% | 0.00% |
01:59pm | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
May. 09 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.72B | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- CGON Stock
- News CG Oncology, Inc.
- CG Oncology, Inc.(NasdaqGS: CGON) added to NASDAQ Composite Index